To elucidate the mechanisms by which YM fusion promotes cancer cell proliferation and survival, we conducted an RNA sequencing (RNA-seq) analysis to compare gene expression between YM/MAML2-depleted (shM2-3) and control (shCtl) ES-2 cells. This evidence concerns the gene MAML2 and cancer.